PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.14 - 0.14
0.08 - 0.20
5.0K / 202.5K (Avg.)
-6.75 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.23%
Negative revenue growth while 8420.HK stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-57.09%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
87.32%
EBIT growth 1.25-1.5x 8420.HK's 64.70%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
85.80%
Operating income growth above 1.5x 8420.HK's 28.33%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
88.51%
Net income growth 1.25-1.5x 8420.HK's 76.27%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
88.57%
EPS growth similar to 8420.HK's 83.33%. Walter Schloss would assume both have parallel share structures and profit trends.
88.57%
Diluted EPS growth at 75-90% of 8420.HK's 99.32%. Bill Ackman would expect further improvements in net income or share count reduction.
-1.15%
Share reduction while 8420.HK is at 18.63%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.20%
Reduced diluted shares while 8420.HK is at 2637.50%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.36%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-76.97%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-111.16%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
78.08%
5Y net income/share CAGR similar to 8420.HK's 71.99%. Walter Schloss might see both on parallel mid-term trajectories.
81.96%
3Y net income/share CAGR 1.25-1.5x 8420.HK's 70.69%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
-85.14%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-83.80%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.63%
Our AR growth while 8420.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-51.21%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.50%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.12%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-84.90%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-81.05%
We cut SG&A while 8420.HK invests at 218.61%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.